Lola Sepot-Boucherit: Reimagining the Future of Rare Bleeding Disorders at ISTH 2026
Lola Sepot-Boucherit, Director Rare Bleeding Disorders at Novo Nordisk, shared a post on LinkedIn:
“Under brilliant Parisian sunshine, the City of Light became a catalyst for scientific exchange, collaboration and innovation at ISTH.
It was a privilege to welcome the global haemostasis community to France and to engage with researchers and healthcare professionals from around the world. Throughout the week, the science on display highlighted how rapidly our field is evolving.
For Novo Nordisk, the congress of the International Society on Thrombosis and Haemostasis (ISTH) also reflected the exciting new chapter we are entering in rare diseases.
As we accelerate research and scientific innovation, the engagement of our Executive Management, including Hong Chow, reinforced our long-term commitment and ambition to help reimagine the future of care for people living with rare bleeding disorders.
It was also a real pleasure to welcome so many Novo Nordisk colleagues to Paris, share a little of the French art de vivre, and spend this memorable week alongside our amazing French team.
See you next year in Vancouver!”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Jul 21, 2026, 01:44Megan Preece: Presenting New Research on Antiphospholipid Syndrome at ISTH 2026
-
Jul 21, 2026, 01:28Dhamirah Nazihah Mohd Nasiruddin: A Milestone in My Haemostasis and Thrombosis Journey at ISTH 2026
-
Jul 21, 2026, 00:55Anita Brikman on PPTA’s First-Half 2026 Achievements
-
Jul 21, 2026, 00:50Caitlin Raymond: Can Therapeutic Plasma Exchange Reduce Microplastics?
-
Jul 21, 2026, 00:46Yohei Hisada: Science, Collaboration, and New Beginnings at ISTH 2026
-
Jul 21, 2026, 00:41Ahmed Koriesh: Inside Our 2026 Stroke Simulation Lab
-
Jul 20, 2026, 21:17Connie Montgomery: Building Community Through the HFA Black Voices Summit
-
Jul 20, 2026, 21:15Leonie Bolt: Honored to Present on Coronary Artery Calcium Scoring in Hemophilia A at ISTH 2026
-
Jul 20, 2026, 21:12Mihir Jain: Can Gene Therapy Transform Hemophilia Care in India?